Upload
tiponya-gonzalez
View
31
Download
1
Tags:
Embed Size (px)
DESCRIPTION
Dosing Regimen Design. Nonlinear Kinetics. Saturable metabolism. When elimination is “linear”, CL is independent of the amount of drug in the body and the steady-state plasma concentration is directly proportional to the dosing rate: C ss = K o /CL C ss,av = F •Dose/CL . - PowerPoint PPT Presentation
Citation preview
Dosing Regimen Design
Nonlinear Kinetics
Saturable metabolism
When elimination is “linear”, CL is independent of the amount of drug in the body and the steady-state plasma concentration is directly proportional to the dosing rate:
Css = Ko/CL
Css,av = F•Dose/CL
Michaelis Menten Kinetics
dtEDd
CKCV
vM
max
1
32
kkk
KM
Michaelis-Menten Kinetics and Dosing Rate
Rate In = Rate Out
ssM
sso CK
CVK
max
o
oMss KV
KKC
max 0
5
10
15
20
25
0 100 200 300 400 500
Dose Rate [mg/h]
Cp
,ss
[m
g/L
]
CL=Vmax/Km
CL=Vmax/(Km+Cp,ss)
Vmax = 500 mg/h
KM = 4 mg/L
Non-linear relationship
As dose rate increases, there is a more-than-proportional increase in Cp,ss.
FDM/
Ko
Cp,ss CL
“Amplifier” or “positive feedback loop”
Example: phenytoinTherapeutic Window: 10-20 mg/L
Patient values of KM and Vmax: 3 mg/L & 425 mg/day.
Patient is taking 200 mg po b.i.d.
F = 0.85; DR = (0.85)(400 mg) = 340 mg/day
Css = KMDR/(Vmax - DR)
= (3mg/L)(340 mg/day)/(425 – 340 mg/day)
= 12 mg/LIf F increased to 0.95 because of product change, DR would be 380 mg/day and Css would be:
Css = (3)(380)/(425 – 380) = 25.3 mg/L
Time to steady state
As metabolism becomes saturated by escalating body level, CL is reduced and half life is increased. Time to steady state is thereby increased:
Rowland and Tozer, Fig. 22.15, p. 410.
= t90%
Change in CL also gets amplified
FDM/
Ko
Cp,ss CL
Principal examples of single saturable metabolism pathway: phenytoin and ethanol.Another possibility is that the drug is eliminated by several pathways, only some of which are saturable. Examples include salicylate, propranolol, and theophylline.
0.01
0.1
1
10
100
1000
10000
1 10 100 1000 10000
Ko, mg/hr
Css
, m
g/L
Parallel linear and saturable pathways
Db
CLlin = 1L/h
CLsat
KM = 2.22 mg/L
Vmax = 100 mg/h
CL = CLlin + CLsat
When Css << KM, CL = 100/2.22 + 1 = 46 L/h
When Css >> KM, CL 1 L/h
Two Plateaus
With parallel linear and saturable pathways, the Css vs. Ko relationship has two plateaus, below and above the KM of the saturable pathway.
With the parallel pathways system, saturation of one pathway is clinically important only when the saturable pathway accounts for more than 50% of CL in the linear region.
Ko
ke
Vmax, KM
Ko, mg/h Css, mg/L
1 0.022
2 0.044
4 0.090
7 0.163
10 0.240
25 0.713
50 2.05
100 13.8
250 151
500 401
1000 900
2500 2400
5000 4900
10000 9900
Ko
ke
Vmax, KM
linear
nonlinear
linear
Mo
eMeo
Meo
ess K
V
KkKk
V
VKKk
V
VK
kC 4
2
12
maxmax
Autoinduction: carbamazepine
tk
k
NktK
K
NK
Ea
ap
a
a
atE
tE
tE
ee
ee
e
e
Kk
k
V
DoseFC
1
1
1
1
tKEEE
tE
IeKKKK 0
Rowland and Tozer, Fig. 23-6, p. 430.
t1/2,I = 3.5 days
KE, /KE,0 = 2
KE
t
Pitlick, Levy, et al., J. Pharm. Sci. 65:462,1976.